Search Results

Combination of a Topical Anti-Inflammatory Drug and a Moisturizer, Both with a Lamellar Structure Containing Synthetic Pseudo-Ceramides, for the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis

• Authors : Okoshi, Keita; Ito, Shotaro; Matsuoka, Megumi

• Source: Clinical, Cosmetic and Investigational Dermatology. July 31, 2024, Vol. 17, p1569, 10 p.

Record details

Successful Treatment of Chronic Actinic Dermatitis with Tofacitinib

• Authors : Zhong, Jianbo; Ali, Kamran; Yang, Ping

• Source: Clinical, Cosmetic and Investigational Dermatology. March 1, 2024, Vol. 17, p399, 9 p.

Record details

Research from Sichuan Mental Health Center Provides New Study Findings on Atopic Dermatitis (Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network ...)

• Source: Health & Medicine Week. 2024, pages. 5039

Record details

Report Summarizes Atopic Dermatitis Study Findings from School of Medicine (Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis).

• Source: Health & Medicine Week. 2024, pages. 3919

Record details

FDA Approves VTAMA[R] (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older.

• Source: Business Wire. 2024.

Record details

Research in the Area of Pruritus Reported from University of Miami Miller School of Medicine (Treatment of Brachioradial Pruritus: A Tertiary Center Retrospective Analysis).

• Source: Health & Medicine Week. 2024, pages. 5128

Record details

FDA Approves Lilly's EBGLYSS[TM] (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis.

• Source: Benzinga.com. 2024.

Record details

FDA Approves Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis.

• Source: PR Newswire. 2024.

Record details

Research from Sichuan Mental Health Center Provides New Study Findings on Atopic Dermatitis (Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network ...)

• Source: Health & Medicine Week. December 13, 2024, 5039

Record details

Report Summarizes Atopic Dermatitis Study Findings from School of Medicine (Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis)

• Source: Health & Medicine Week. December 13, 2024, 3919

Record details